How Emergent BioSolutions EBS geographic mix shifted this quarter Q1 2026 EPS Exceeds Expectations Gilead Sciences Inc GILD Schedules Participation at Four Leading Q2 2026 Healthcare Investor Conferences to Update Stakeholders on Pipeline and Operational Milestones Why New Era NUAI is still under the radar Volatility Increases 20260508 How does Oncolytics ONCY reward shareholders Technical Weakness 20260429 HUHU HUHUTECH reports quarterly results with AIdriven growth offsetting margin concerns CEO emphasizes strategic expansion plans VIASP Via quarterly earnings metrics not yet released market participants await key strategic updates from leadership FFIV F5 Q1 2026 EPS beats estimates by 106 percent shares climb 117 percent on solid results How PT TLK returns capital to shareholders PT posts 135 EPS miss amid operational headwinds PriceSmart PSMT Stock Jumps 192 Approaching 17290 20260520